Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple endogenous growth factor receptors and regenerative pathways is a collective term used in drug development and regenerative medicine to describe a broad network of signaling systems rather than a single molecular entity. This target profile encompasses several families of cell-surface receptors, primarily receptor tyrosine kinases (RTKs) such as the Platelet-Derived Growth Factor Receptor (PDGFR), Fibroblast Growth Factor Receptor (FGFR), and Epidermal Growth Factor Receptor (EGFR), which are essential for mediating cell proliferation and migration during tissue repair (Werner & Grose, 2003, Physiol Rev). It also includes highly conserved developmental pathways like Wnt/beta-catenin and Notch signaling, which are critical for stem cell maintenance and the induction of regenerative windows in tissues like the skin and hair follicles (Clevers et al., 2014, Science). In clinical practice, this multi-target approach is often associated with therapies like platelet-rich plasma (PRP), conditioned media, or combination device-drug treatments (e.g., micro-wounding followed by topical agents) aimed at treating chronic wounds, ischemia, or androgenetic alopecia (Gurtner et al., 2008, Nature). By stimulating multiple pathways simultaneously, these therapies attempt to mimic the natural physiological environment of embryonic development or active healing. However, the complexity of these interconnected pathways presents significant therapeutic challenges; the primary concern is maintaining a balance between beneficial regeneration and the risk of pathological overgrowth, such as fibrosis or the development of neoplasms (AdisInsight, 2024).
Simultaneous activation of various cell-surface receptor tyrosine kinases (RTKs) and developmental signaling cascades (e.g., Wnt, Notch, Hedgehog) to stimulate cellular division, migration, and tissue remodeling.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple endogenous growth factor receptors and regenerative pathways.